Start-Up Previews (10/2010)
Executive Summary
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Eyeing New Drugs For Glaucoma," features profiles of Altheos, Amakem and Mimetogen Pharmaceuticals. Plus these Start-Ups Across Health Care: Aragon Surgical, Arcarios, Carolina BioPharm, Miromatrix Medical and Pathogenica.
You may also be interested in...
Aragon Surgical Inc.
Unlike the unwieldy "Jaws" of the blockbuster movie, the clamping jaws located at the tip of a new electrosurgical instrument from Aragon Surgical. are designed to help surgeons precisely seal and cut both tissues and vessels easier, faster, and more durably. The Caiman system is powered by proprietary Lektrafuse technology, consisting of a radiofrequency energy generator that delivers bipolar energy via a sophisticated algorithm.
Miromatrix Medical Inc.
Regenerative medicine start-up Miromatrix Medical is working to commercialize a technology known as perfusion decellularization. Its proprietary, patent-protected technology involves the decellularization of any vascularized tissue, up to and including whole organs, leaving behind a completely preserved native scaffold (matrix) that retains the original architecture, mechanical properties and vascular network of the tissue or organ. This scaffold can then be repopulated with vascular- and organ-specific regenerative cells and, under controlled conditions in a bioreactor, a biocompatible, functioning organ or tissue is created.
Pathogenica Inc.
Pathogenica, co-founded by Harvard's George Church, PhD, views itself as an "apps" company for a variety of human genome sequencing platforms. Its BioDetection system has the potential to screen thousands of samples, each tested for hundreds of unique pathogen strains at a predicted cost of less than one dollar per pathogen. The start-up aims to enable effective and affordable pathogen sequencing in a wide range of markets - physician, veterinary, and farming - not just scientific.